openPR Logo
Press release

Pharmacogenomics Market Worth $13.16 billion by 2029

07-12-2023 09:24 AM CET | Health & Medicine

Press release from: Meticulous Research®

/ PR Agency: Meticulous
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'

Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366

According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period 2022-2029. The growth of this market is driven by growing therapeutic applications of pharmacogenomics biomarkers, increasing adoption of personalized medicine, rising geriatric population and chronic disease prevalence, and growing awareness of adverse drug reactions. However, the high cost of personalized medicine and a lack of reimbursement for genetic testing & precision medicine restrain the market growth. The increasing application of pharmacogenomics in neurological disorders and cancer and the development of new, more advanced, and accurate diagnostic tools are creating growth opportunities for this market. However, the low awareness of pharmacogenomics/personalized medicine among people and the knowledge gap about genetic testing and its benefits pose a challenge to this market.

Pharmacogenomics Market: Future Outlook

The global pharmacogenomics market is segmented by technology (polymerase chain reaction, DNA sequencing, electrophoresis, microarray, mass spectrometry, and other technologies), application (oncology, cardiology, neurological diseases, infectious diseases, and other applications), end user (hospitals, diagnostic laboratories, academic and research institutions and other end users), and geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Speak to Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5366

Based on technology, in 2022, the polymerase chain reaction segment is expected to account for the largest share of the pharmacogenomics market. The large market share of this segment is attributed to the high availability and usage of PCR across all end users. PCR is a cost-effective alternative to NGS and other technologies. Moreover, PCR is a highly sensitive technology and provides results with high accuracy and low sample volume requirement. These benefits of PCR allow for its high adoption across all end users.

Based on application, in 2022, the oncology segment is expected to account for the largest share of the pharmacogenomics Market. The large market share of this segment is attributed to the need for more targeted approaches in cancer therapy, the benefits offered by pharmacogenomics in cancer treatment, and the prevalence of cancer worldwide. The high prevalence of cancer globally calls for early detection and targeted cancer therapy to reduce mortality due to cancer. According to the International Agency for Research on Cancer, the estimated global number of new cancer cases in 2020 was around 19.3 million.

Quick Buy @ https://www.meticulousresearch.com/Checkout/62981808

Based on end user, in 2022, the hospitals segment is expected to account for the largest share of the Pharmacogenomics Market. Hospitals are the primary preference for diagnosing and treating any chronic or infectious disease. There is a rising trend among hospitals to equip themselves with molecular diagnostics tools. Moreover, the presence of certified medical practitioners in hospitals contributes to the higher adoption of pharmacogenomics testing. These factors further boost the growth of the pharmacogenomics market.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. Based on geography, in 2022, North America is expected to account for the largest share of the global pharmacogenomics market, followed by Europe and Asia-Pacific. The high prevalence of chronic diseases and high awareness regarding risks of diseases in the future, technological advancements in molecular and sequencing technologies, and highly developed healthcare infrastructure support the large market share of this region.

The key players operating in the global pharmacogenomics Market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), OPKO Health, Inc. (U.S.), Dynamic DNA Laboratories (U.S.), Admera Health (U.S.), Qiagen N.V. (Netherlands), and Myriad Genetics, Inc. (U.S.).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/pharmacogenomics-market-5366

Key questions answered in the report-

1 What is the current value of revenue generated by pharmacogenomics products across the globe?
2 At what rate is the demand for global pharmacogenomics products projected to grow for the next 5-7 years?
3 What is the historical market size and growth rate for pharmacogenomics across the globe?
4 What are the major factors impacting the growth of this market at the global and regional levels?
5 What are the major opportunities for existing market players and new entrants in the market?
6 What impact does the current COVID-19 pandemic have on the pharmacogenomics market at various levels in the value chain?
7 Which segments are creating major traction for the vendors in this market in terms of the technology, application and end user?
8 What are the key geographical trends in this market?
9 Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the Global pharmacogenomics Market?
10 Who are the major players in the global pharmacogenomics market? And what are their specific products in the Pharmacogenomics industry?
11 What recent developments have taken place in the global pharmacogenomics market, and how these strategic developments are creating a global impact in this market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Meticulous Research®
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market Worth $13.16 billion by 2029 here

News-ID: 3125085 • Views:

More Releases from Meticulous Research®

Autonomous AI and Autonomous Agents Market Poised for Massive Growth
Autonomous AI and Autonomous Agents Market Poised for Massive Growth
The global autonomous AI and autonomous agents market is witnessing exponential expansion, driven by rapid advancements in machine learning, deep learning, and artificial intelligence adoption across multiple industries. Valued at USD 7.91 billion in 2024, the market is projected to reach USD 11.5 billion in 2025 and surge to a staggering USD 477.8 billion by 2035, registering a CAGR of 45.2% during the forecast period. As industries increasingly look for ways
AI-Generated Fashion Market to Reach $75.9 Billion by 2035 | Meticulous Research
AI-Generated Fashion Market to Reach $75.9 Billion by 2035 | Meticulous Research
AI-Generated Fashion Market Overview The global AI-generated fashion market is experiencing explosive growth as artificial intelligence reshapes the way clothing, footwear, and accessories are designed, marketed, and consumed. The market was valued at USD 2.14 billion in 2024 and is expected to reach USD 2.91 billion in 2025. Looking further ahead, it is projected to skyrocket to nearly USD 75.9 billion by 2035, growing at a staggering CAGR of 38.6%. This
Enterprise Data Visualization Market Size, Share & Forecast 2035 | Meticulous Research
Enterprise Data Visualization Market Size, Share & Forecast 2035 | Meticulous Re …
Enterprise Data Visualization System Market Overview The global enterprise data visualization system market is on a remarkable growth path. Valued at USD 9.75 billion in 2024, it is expected to reach USD 11.13 billion in 2025 and surge to nearly USD 40.16 billion by 2035, expanding at a robust CAGR of 13.6% during the forecast period. This rapid growth highlights the increasing importance of data visualization as organizations strive to transform
Enterprise Generative AI Market to Witness Explosive Growth by 2035 | Meticulous Research
Enterprise Generative AI Market to Witness Explosive Growth by 2035 | Meticulous …
The enterprise generative AI market is entering a transformative era as businesses worldwide embrace artificial intelligence to drive innovation, enhance customer engagement, and optimize operations. Generative AI, which refers to algorithms and models capable of creating new content such as text, images, audio, and code, is no longer confined to research labs or niche applications. It has rapidly moved into mainstream enterprise use cases, reshaping industries like IT & telecom,

All 5 Releases


More Releases for America

Deodorants Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Deodorants market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Sequestrant Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Sequestrant market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Buttermilk Market Study by Region (North America, Latin America, Europe, Asia, M …
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Buttermilk market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%),
Masterbatches Market Study by Region (North America, Latin America, Europe, Asia …
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Masterbatches market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%),
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth